P576: A PHASE I/II STUDY OF MILADEMETAN (DS3032B) IN COMBINATION WITH LOW DOSE CYTARABINE WITH OR WITHOUT VENETOCLAX IN ACUTE MYELOID LEUKEMIA

P576: A PHASE I/II STUDY OF MILADEMETAN (DS3032B) IN COMBINATION WITH LOW DOSE CYTARABINE WITH OR WITHOUT VENETOCLAX IN ACUTE MYELOID LEUKEMIA

מידע ביבליוגרפי
Main Authors: J. Senapati, J. Ishizawa, H. A. Abbas, S. Loghavi, G. Borthakur, G. C. Issa, S. I. Dara, R. Pourebrahim, N. Daver, E. J. Jabbour, S. M. Kornblau, N. Pemmaraju, G. Garcia-Manero, F. Ravandi, M. Muftuoglu, J. Khoury, C. DiNardo, M. Andreeff
פורמט: Article
שפה:English
יצא לאור: Wiley 2022-06-01
סדרה:HemaSphere
גישה מקוונת:http://journals.lww.com/10.1097/01.HS9.0000845192.65192.c0

אינטרנט

http://journals.lww.com/10.1097/01.HS9.0000845192.65192.c0

פריטים דומים